Early Immunotherapy With Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients With Anti-Hu-associated Paraneoplastic Sensory Neuronopathy
Conditions: Paraneoplastic Sensory Neuronopathy Interventions: Drug: Immunoglobulins IV (CLAYRIG); Drug: Cyclophosphamide IV; Drug: Methylprednisolone IV Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Methylprednisolone Adjunctive to Endovascular Treatment for Stroke
Conditions: Acute Ischemic Stroke Interventions: Drug: Methylprednisolone Sponsors: Wan-Jin Chen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Conditions: Plasma Cell Myeloma Refractory Interventions: Drug: Isatuximab SC-OBDS; Drug: Montelukast; Drug: Dexamethasone; Drug: Acetaminophen; Drug: Diphenhydramine; Drug: Methylprednisolone; Drug: Carfilzomib Sponsors: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection
Conditions: Sacroiliac Joint Dysfunction; Sacro-Iliac Spondylosis Interventions: Drug: Dexamethasone; Drug: Methylprednisolone Sponsors: University of New Mexico Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Severe Erythema Multiforme - CORTICO
Conditions: Erythema Multiforme Interventions: Drug: Prednisone 20 Mg; Drug: Oral Placebo; Drug: Methylprednisolone 120 Mg; Drug: IV Placebo Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
A Trial of Selinexor, Ruxolitinib and Methylprednisolone
Conditions: Multiple Myeloma in Relapse; Multiple Myeloma, Refractory Interventions: Drug: Selinexor; Drug: Ruxolitinib; Drug: Methylprednisolone Sponsors: Oncotherapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration
Conditions: Methylprednisolone; Intranasal Administration; Patients With an Active Multiple Sclerosis Relapse Interventions: Other: IV Methylprednisolone administration; Drug: Nasal Methylprednisolone (MT) Sponsors: Universidad Nacional Autonoma de Mexico; Instituto Nacional de Neurolog ía y Neurocirugía Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Drug: Ruxolitinib Oral Tablet [Jakafi]; Drug: Lenalidomide; Drug: Methylprednisolone Sponsors: Oncotherapeutics; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Histopathological, Biochemical And Electrophysiological Evaluation Of Single Or Combined Use Of Diode Laser/Steroid Treatment On Facial Nerve Injury
Conditions: Nerve Injury; Laser Therapy; Methylprednisolone; Facial Nerve Injuries Interventions: Drug: Methyprednisolon and low level laser theraphy Sponsors: Recep Tayyip Erdogan University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma
Conditions: Asthma Acute Interventions: Drug: Methylprednisolone, Sponsors: University of Karachi Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)
DiscussionWe hypothesize that pulse-dose methylprednisolone administrated in the pre-hospital setting decreases inflammation and thus reduces final infarct size in patients with STEMI treated with primary PCI.Trial registrationEU-CT number: 2022 –500762-10–00; Submitted May 5, 2022. ClinicalTrials.gov Identifier: NCT05462730; Submitted July 7, 2022, first posted July 18, 2022. (Source: Trials)
Source: Trials - December 15, 2023 Category: Research Source Type: clinical trials
Comparison of Efficacy of Intra-articular Morphine vs Methylprednisolone in Patients With Knee Osteoarthritis.
Conditions: Osteoarthritis, Knee Interventions: Drug: Methylprednisolone 40 MG Injection Sponsors: Henry Ford Health System Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
TAP Block With Methyl-prednisolone as a Pain Treatment Modality After Total Abdominal Hysterectomy Procedures
Conditions: Local Anesthetic; Ultrasound; Pain, Acute Interventions: Drug: TAPB with dexamethasone as an adjuvant to local anesthetics; Drug: TAPB with methylprednisolone as an adjuvant to local anesthetics Sponsors: Kasr El Aini Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
Conditions: Toxic Epidermal Necrolysis Interventions: Drug: Abrocitinib Sponsors: Peng Zhang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
Conditions: Neuromyelitis Optica; Efgartigimod Interventions: Drug: Intravenous methylprednisolone (IVMP) and Efgartigimod; Drug: IVMP Sponsors: Feng Jinzhou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
